Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Severe Psoriasis”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00808223
What this trial is testing

Safety and Pharmacokinetics (PK) of Alefacept in Adolescent Subjects With Moderate to Severe Psoriasis

Who this might be right for
Psoriasis
Astellas Pharma Inc 30
Post-approval studies (Phase 4)Study completedNCT01644396
What this trial is testing

An Open-Label, Prospective Study to Assess the Safety and Effectiveness of Adalimumab in Patients With Moderate to Severe Plaque Psoriasis in the Russian Federation

Who this might be right for
Moderate to Severe Plaque Psoriasis
AbbVie (prior sponsor, Abbott) 50
Large-scale testing (Phase 3)WithdrawnNCT02795416
What this trial is testing

Assessment of Efficacy and Safety of Secukinumab in Adult Patients in Turkish Population

Who this might be right for
Psoriasis
Novartis Pharmaceuticals
Large-scale testing (Phase 3)Study completedNCT06398652
What this trial is testing

Comparative Study of CMAB015 and Secukinumab for Patients With Moderate to Severe Plaque Psoriasis

Who this might be right for
Psoriasis
Taizhou Mabtech Pharmaceutical Co.,Ltd 336
Not applicableStudy completedNCT04818385
What this trial is testing

Study to Assess the Change in Disease State When Subcutaneous Risankizumab Injection is Given to Adult Participants With Psoriasis in Taiwan

Who this might be right for
Psoriasis
AbbVie 240
Large-scale testing (Phase 3)Study completedNCT02951533
What this trial is testing

Compare the Efficacy of Guselkumab to Fumaric Acid Esters for the Treatment of Participants With Moderate to Severe Plaque Psoriasis

Who this might be right for
Psoriasis
Janssen-Cilag G.m.b.H 119
Testing effectiveness (Phase 2)Study completedNCT04172233
What this trial is testing

A Clinical Study of AK101 in Subjects With Moderate to Severe Plaque Psoriasis

Who this might be right for
Plaque Psoriasis
Akeso 96
Large-scale testing (Phase 3)Study completedNCT03066609
What this trial is testing

Study of Efficacy and Safety of Secukinumab in Subjects With Moderate to Severe Chronic Plaque-type Psoriasis

Who this might be right for
Plaque Psoriasis
Novartis Pharmaceuticals 543
Testing effectiveness (Phase 2)Study completedNCT04855721
What this trial is testing

A Dose-Ranging Phase II Study of AUR101 in Psoriasis (INDUS-3)

Who this might be right for
Plaque Psoriasis
Aurigene Discovery Technologies Limited 141
Post-approval studies (Phase 4)Study completedNCT06336343
What this trial is testing

Bimekizumab in Plaque Psoriasis

Who this might be right for
Plaque Psoriasis
Icahn School of Medicine at Mount Sinai 60
Large-scale testing (Phase 3)Not Yet RecruitingNCT06672393
What this trial is testing

Confirm Efficacy and Safety of HS-10374 for Moderate to Severe Plaque Psoriasis

Who this might be right for
Psoriasis
Hansoh BioMedical R&D Company 375
Testing effectiveness (Phase 2)Ended earlyNCT00162253
What this trial is testing

Study of BMS-587101 in Patients With Moderate to Severe Psoriasis

Who this might be right for
Psoriasis, Moderate to Severe
Bristol-Myers Squibb 120
Testing effectiveness (Phase 2)Study completedNCT00645892
What this trial is testing

Extension Study of Two Dosing Schedules of Adalimumab in Subjects With Moderate to Severe Chronic Plaque Psoriasis

Who this might be right for
Psoriasis
Abbott 32
Post-approval studies (Phase 4)Ended earlyNCT04533737
What this trial is testing

Efficacy and Safety of Brodalumab Compared With Guselkumab in the Treatment of Plaque Psoriasis After Inadequate Response to Ustekinumab

Who this might be right for
Plaque PsoriasisPsoriasis VulgarisPsoriasis
LEO Pharma 113
Large-scale testing (Phase 3)Study completedNCT01544595
What this trial is testing

Extension Study of Secukinumab Prefilled Syringes in Subjects With Moderate to Severe Chronic Plaque-type Psoriasis Completing Preceding Psoriasis Phase III Studies With Secukinumab

Who this might be right for
Moderate to Severe Plaque-type Psoriasis
Novartis Pharmaceuticals 1,147
Large-scale testing (Phase 3)Study completedNCT01265667
What this trial is testing

Trial of CF101 to Treat Patients With Psoriasis

Who this might be right for
Plaque Psoriasis
Can-Fite BioPharma 293
Testing effectiveness (Phase 2)Study completedNCT05096364
What this trial is testing

Efficacy and Safety of AK111 in Subjects With Moderate-to-Severe Psoriasis

Who this might be right for
Psoriasis
Akeso 251
Testing effectiveness (Phase 2)UnknownNCT03745417
What this trial is testing

Efficacy and Safety of Expanded UCMSCs On Patients With Moderate to Severe Psoriasis

Who this might be right for
Mesenchymal Stromal CellsPsoriasisDrug Effect+1 more
Guangdong Provincial Hospital of Traditional Chinese Medicine 5
Early research (Phase 1)UnknownNCT03675542
What this trial is testing

The Safety and Efficacy of a Novel HSP90 Inhibitor (CUDC-305) in the Treatment of Moderate to Severe Psoriasis.

Who this might be right for
Psoriasis Vulgaris
Aarhus University Hospital 16
Testing effectiveness (Phase 2)Study completedNCT00292396
What this trial is testing

Efficacy and Safety of ABT-874 in Subjects With Moderate to Severe Chronic Plaque Psoriasis

Who this might be right for
Psoriasis
AbbVie (prior sponsor, Abbott) 180
Next Page